Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, United States; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, United States
Kuang Shen
Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, United States
Yang Wang
MassBiologics of the University of Massachusetts Chan Medical School, Boston, United States
Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, United States; Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, United States
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects cells through binding to angiotensin-converting enzyme 2 (ACE2). This interaction is mediated by the receptor-binding domain (RBD) of the viral spike (S) glycoprotein. Structural and dynamic data have shown that S can adopt multiple conformations, which controls the exposure of the ACE2-binding site in the RBD. Here, using single-molecule Förster resonance energy transfer (smFRET) imaging, we report the effects of ACE2 and antibody binding on the conformational dynamics of S from the Wuhan-1 strain and in the presence of the D614G mutation. We find that D614G modulates the energetics of the RBD position in a manner similar to ACE2 binding. We also find that antibodies that target diverse epitopes, including those distal to the RBD, stabilize the RBD in a position competent for ACE2 binding. Parallel solution-based binding experiments using fluorescence correlation spectroscopy (FCS) indicate antibody-mediated enhancement of ACE2 binding. These findings inform on novel strategies for therapeutic antibody cocktails.